Versaflex™ HC and Versaflex HC BIO Thermoplastic Elastomers (TPEs): These specialty TPE formulations offer versatile and customizable performance for medical and biopharmaceutical tubing, device overmolds, and injection molded applications. Available in a variety of durometers and performance characteristics, the product family includes grades formulated without animal derivatives and a bio-based Versaflex HC BIO BT218 formulation developed specifically to handle the complexities of biopharmaceutical tubing (excellent weldability, kink resistance, and low levels of leachables and extractables) with a lower carbon footprint than traditional Versaflex HC TPE or silicone alternatives.

Versaflex™ HC TPEs  offer performance, patient comfort, and sustainability.  ColorMatrix™ Amosorb™ Oxyloop-1 O₂ Scavenging Additive to Enhance Recycling Enhancing Recycling and Shelf Life with ColorMatrix™ Amosorb™ Oxyloop-1

Versaflex™ HC TPEs  offer performance, patient comfort, and sustainability.  ColorMatrix™ Amosorb™ Oxyloop-1 O₂ Scavenging Additive to Enhance Recycling Enhancing Recycling and Shelf Life with ColorMatrix™ Amosorb™ Oxyloop-1

Versaflex™ HC TPEs  offer performance, patient comfort, and sustainability.  ColorMatrix™ Amosorb™ Oxyloop-1 O₂ Scavenging Additive to Enhance Recycling Enhancing Recycling and Shelf Life with ColorMatrix™ Amosorb™ Oxyloop-1

X SR15031-001-1 VERSAFLEX(TM) MD6843 N VERSAFLEX(TM) G2832 N

Versaflex™ HC TPEs  offer performance, patient comfort, and sustainability.  ColorMatrix™ Amosorb™ Oxyloop-1 O₂ Scavenging Additive to Enhance Recycling Enhancing Recycling and Shelf Life with ColorMatrix™ Amosorb™ Oxyloop-1

Versaflex™ HC TPEs  offer performance, patient comfort, and sustainability.  ColorMatrix™ Amosorb™ Oxyloop-1 O₂ Scavenging Additive to Enhance Recycling Enhancing Recycling and Shelf Life with ColorMatrix™ Amosorb™ Oxyloop-1

P l O I t P t tiPolyOne Investor Presentation KeyBanc Capital Markets Basic Materials & Packaging Conference September 2016p PolyOne Corporation Page 1 Forward-Looking Statements  In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. PolyOne Corporation Page 3 PolyOne Commodity to Specialty Transformation 2000-20052000-2005 2006 - 20092006 - 2009 2010 – 20152010 – 2015 2016 and beyond 2016 and beyond • Steve Newlin appointed, Chairman, • Steve Newlin appointed, Chairman, • Substantial EPS growth from $0.13 to all-time high of $1.96 • Substantial EPS growth from $0.13 to all-time high of $1.96 • Deliver consistent double digit annual EPS growth • Deliver consistent double digit annual EPS growth • Volume driven, commodity producer • Volume driven, commodity producer pp , , President and CEO • New leadership team appointed pp , , President and CEO • New leadership team appointed • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel • Maintain >35% vitality index • Pursue strategic i iti th t • Maintain >35% vitality index • Pursue strategic i iti th t • Heavily tied to cyclical end markets • Heavily tied to cyclical end markets • Implementation of four pillar strategy • Implementation of four pillar strategy y q p p current and future growth, as well as margin expansion • Specialty mix expands y q p p current and future growth, as well as margin expansion • Specialty mix expands acquisitions that expand specialty offerings and geographic breadth acquisitions that expand specialty offerings and geographic breadth • Performance largely dependent on non- controlling joint ventures • Performance largely dependent on non- controlling joint ventures • Focus on value based selling, investment in commercial resources and innovation to drive transformation • Focus on value based selling, investment in commercial resources and innovation to drive transformation to 65% of Operating Income – strongest mix of earnings in history to 65% of Operating Income – strongest mix of earnings in history • Invest and grow current and next generation talent • Invest and grow current and next generation talent PolyOne Corporation Page 4 Confirmation of Our Strategy SpecializationSpecialization GlobalizationGlobalization Associates Operational Excellence Operational Excellence Commercial Excellence Commercial Excellence Th W ld’ P i P id f S i li d PolyOne Corporation Page 5 The World’s Premier Provider of Specialized Polymer Materials, Services and Solutions 27 Consecutive Quarters of EPS Growth PolyOne Corporation Page 6 PolyOne At A Glance 2015 Revenues: $3.4 Billion2015 Revenues: $3.4 Billion 2015 Revenues: $3.4 Billion2015 Revenues: $3.4 Billion Europe 13% Canada 7% Asia 7% Latin America 7% PP&S 20% United States Distribution 29% CAI 23% SEM %DSS End MarketsEnd Markets Adjusted EPSAdjusted EPS 66% 15%DSS 13% End MarketsEnd Markets $1.31 $1.80 Adjusted EPSAdjusted EPS Industrial 14% Packaging 13% Textiles 2% Transportation $1.96 $0 27 $0 21 $0.68 $0.82 $1.00 $1.31 Building & C Consumer Healthcare 11% 20% Wire & Cable 9% PolyOne Corporation Page 7 $0.12 $0.27 $0.21 $0.13 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 Appliances 4% Construction 12% 10%Electrical & Electronics 5% Mix Shift Highlights Specialty Transformation Old PolyOne 100% Transformation 2020 Platinum Vision 80% nc om e* 40% 60% pe ra tin g In 80%+ 43% 65% 20% 40% % o f O 2%0% 2005 2010 2015 2020 Specialty OI $5M $87M $229M Platinum Vision PolyOne Corporation Page 8 *Operating Income excludes corporate charges and special items JV's Performance Products & Solutions Distribution Specialty Vision Color and Engineered Materials at the Heart of Specialty Transformation OPERATING MARGIN 16.7% 17.5% 20%+ COLOR, ADDITIVES AND INKS 15 8% 20%+ SPECIALTY ENGINEERED MATERIALS 9.7% 12.2% 14.7% 9.6% 9.3% 12.1% 14.7% 15.8% 1 7% 4.6% 5.1% 5.5% 7.2% 8.1% 3.4% 5.1% 8.0% 8.6% 1.7% 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2Q'16 2020 Platinum Vision 1.1% 1.3% 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2Q'16 2020 Platinum Vision YTD YTD PolyOne Corporation Page 9 Proof of Performance & 2020 Goals 2006 2Q 2016 2020 “Where we were” “Where we are” Platinum Vision 1) Operating Income %1) Operating Income % Specialty: Color, Additives & Inks 1.7% 18.0% 20%+ S i lt E i d M t i l 1 1% 14 9% 20%+Specialty Engineered Materials 1.1% 14.9% 20%+ Designed Structures & Solutions N/A 1.7% (TTM) 8 – 10% Performance Products & Solutions 5.5% 12.3% 12 – 14% Distribution 2.6% 6.5% 6.5 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 61% 80%+ 3) ROIC* 5.0% 12.0% 15% 4) Adjusted EPS Growth N/A 11% Double Digit PolyOne Corporation Page 10 ) j % Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period TPE’s & Film Therma-Tech™ & Sheet GEON™ Vinyl TPE + OnForce™ Gravi-Tech™ Polymer ColorantsTherma-Tech™ Film PolyOne Corporation Page 11Page 11 Target End Markets… Healthcare OnForce (SEM) Glasforms (SEM) TPE + OnForce (SEM) TPE Vibration Dampening (SEM/GLS) Source: Outdoor Industry Association TPE & Film (SEM + DSS) Thermoplastic Elastomers (SEM) TPE O F Glasforms (SEM) Polymer Colorants (CAI) Thermatech (SEM) TPE + OnForce (SEM) OnForce (SEM) Thermoplastic Elastomers (SEM) Sheet (DSS) (SEM) Glasforms (SEM) Polymer Colorants (CAI) PolyOne Corporation Page 12 Target End Markets… Outdoor High Performance Sound & Vibration Management Roof Systems Management Interior & Exterior Trim Interior Structural Components Fuel Handling Underhood Components g SystemsAir management Electronics & Cameras Structural Braces & Brackets Lighting Fluid Handling PolyOne Corporation Page 13 Target End Markets… Automotive ColorMatrix™ Amosorb™ ColorMatrix™ Ultimate™ UV Oxygen Scavenger Ultimate UV Light Barrier PreservaPak™ OnColor™ Smart Batch™ OnCap™ Laser Marking Additives VersaFlex™ TPE Cap Liner PolyOne Corporation Page 14 Target End Markets… Packaging Innovation Drives Earnings Growth $53 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 34% CAI & SEM Gross Margin Target ≥ 35% $20 $53 14% 12% 43% *Specialty Platform revenue from products introduced in last five years 2006 2015 2006 20152006 2015 Innovation Pipeline PotentialInnovation Pipeline Potential PolyOne Corporation Page 15 Ours is Not a Cost Cutting Story VolumeCommercial, R&D Adjusted 2,883 Volume (lbs in millions) $192 Commercial, R&D and Marketing Spending ($M) $721 Adjusted Gross Profit ($M) -16% +86% +138% 2,414$103 $303 2006 20152006 2015 2006 2015 PolyOne Corporation Page 16 Design and Service as a Differentiator Right Material & Color Desired Product Design Appropriate Manufacturing Process Connecting Delivering Concept to Commercialization Connecting the Dots with iQ Design Labs and InVisiO Color Design PolyOne Corporation Page 17 CommercializationInVisiO Color Design Customer First Through World-Class Service Strengthening relationships through:  Providing LSS services to small/medium sized customers  Providing training in Customer Centric Selling Skills with customers On-Time Delivery Commitment to Operational Excellence World’s Best Business Process Excellence Program in 2012* World’s Best Start-up program for Lean Six Sigma Deployment in 2009* 81% 93% 2006 2015 Working Capital % of Sales 16.2% 9.7%  52% of associates trained in LSS PolyOne Corporation Page 18 2006 2015  Five consecutive years – CFO Magazine Best Working Capital Management in the chemical industry Debt Maturities & Pension Funding 102% 100% Pension Funding** As of June 30, 2016 $700 $800 Debt Maturities As of June 30, 2016 ($ millions) 80% 90% 100% $547 $600 $600 $700 60% 60% 70% $500 40% 50% $300 $400 20% 30% 2008 2Q 2016 $200 2022 2023 Coupon Rate: LIBOR + 2 75% 5 250% PolyOne Corporation Page 19 Net Debt / Adjusted EBITDA*= 2.3x ** includes US-qualified pension plans only*TTM 6/30/2016 Coupon Rate: LIBOR + 2.75% 5.250% (3.50%) Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return  Expanding our sales, marketing, and technical capabilities  Investing in operational  Repurchased 17.3 million shares since early 2013  10 0 million shares are Investing in operational and LSS initiatives  ~75% of capital expenditures fund growth initiatives Organic Gro th Share Rep rchases  10.0 million shares are available for repurchase under the current authorization Growth Repurchases Acquisitions Dividends Annual Dividend  Targets that expand our: • Specialty offerings • End market $0.20 $0.32 $0.40 $0.48 $0.30 $0.40 $0.50 • End market presence • Geographic breadth  Synergy opportunities  Adjacent material $0.24 PolyOne Corporation Page 20 $0.16 $ $0.10 $0.20 2011 2012 2013 2014 2015 2016 solutions Why Invest In PolyOne? Adjusted EPS is calculated as follows: Adjusted EPS 2006Y* 2007Y* 2008Y* 2009Y* 2010Y 2011Y 2012Y 2013Y 2014Y 2015Y Net income (loss) attributable to PolyOne common shareholders $ 130.9 $ 40.9 $ (417.0) $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 Joint venture equity earnings, after tax (68.5) (26.1) (20.8) (19.0) (14.7) (3.7) — — — — Special items, after tax(1) (51.2) 10.7 457.2 (75.9) (72.5) (72.8) 36.2 32.6 90.5 28.9 Adjusted net income $ 11.2 $ 25.5 $ 19.4 $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 Diluted shares 92.8 93.1 92.7 93.4 96.0 94.3 89.8 96.5 93.5 88.7 Adjusted EPS $ 0.12 $ 0.27 $ 0.21 $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 Adjusted EPS Q1 2009* Q2 2009* Q3 2009* Q4 2009* Q1 2010 Q2 2010 Q3 2010 Q4 2010 Net income attributable to PolyOne common shareholders $ 3.3 $ 1.3 $ 51.3 $ 50.8 $ 20.1 $ 44.7 $ 0.1 $ 87.6 Joint venture equity earnings, after tax (8.2) (5.8) (3.0) (2.0) (0.5) (4.5) (6.2) (3.5) Special items, after tax(1) (10.2) 9.2 (36.9) (38.0) (3.8) (22.1) 25.4 (72.0) Adjusted net (loss) income $ (15.1) $ 4.7 $ 11.4 $ 10.8 $ 15.8 $ 18.1 $ 19.3 $ 12.1 Diluted shares 92.2 93.5 93.9 94.4 95.3 96.3 96.3 97.4 Adjusted EPS $ (0.16) $ 0.05 $ 0.12 $ 0.11 $ 0.17 $ 0.19 $ 0.20 $ 0.12 Adjusted EPS Q1 2011 Q2 2011 Q3 2011 Q4 2011 Q1 2012 Q2 2012 Q3 2012 Q4 2012 Net income attributable to PolyOne common shareholders $ 106.0 $ 23.1 $ 16.0 $ 8.3 $ 15.3 $ 18.4 $ 19.4 $ 0.2 Joint venture equity earnings, after tax (3.7) - - - - - - - Special items, after tax(1) (81.3) 1.3 2.8 4.4 6.2 8.9 5.4 15.7 Adjusted net income $ 21.0 $ 24.4 $ 18.8 $ 12.7 $ 21.5 $ 27.3 $ 24.8 $ 15.9 Diluted shares 96.4 95.5 94.0 91.9 90.7 90.7 90.2 90.5 Adjusted EPS $ 0.22 $ 0.26 $ 0.20 $ 0.14 $ 0.24 $ 0.30 $ 0.28 $ 0.18 2 Adjusted EPS Q1 2013 Q2 2013 Q3 2013 Q4 2013 Q1 2014 Q2 2014 Q3 2014 Q4 2014 Net income (loss) attributable to PolyOne common shareholders $ 11.2 $ 38.6 $ 23.2 $ 21.0 $ 29.4 $ 30.9 $ 32.3 $ (14.6) Special items, after tax(1) 17.7 (2.0) 12.3 4.6 12.5 17.4 13.1 47.5 Adjusted net income $ 28.9 $ 36.6 $ 35.5 $ 25.6 $ 41.9 $ 48.3 $ 45.4 $ 32.9 Diluted shares 92.8 99.1 98.1 97.2 95.7 94.3 93.1 91.3 Adjusted EPS $ 0.31 $ 0.37 $ 0.36 $ 0.26 $ 0.44 $ 0.51 $ 0.49 $ 0.36 Adjusted EPS Q1 2015 Q2 2015 Q3 2015 Q4 2015 Q1 2016 Q2 2016 Net income attributable to PolyOne common shareholders $ 30.2 $ 66.8 $ 44.5 $ 3.1 $ 39.1 $ 50.0 Special items, after tax(1) 11.4 (15.9) 3.0 30.4 9.1 3.2 Adjusted net income $ 41.6 $ 50.9 $ 47.5 $ 33.5 $ 48.2 $ 53.2 Diluted shares 90.1 89.8 88.4 86.6 85.5 84.7 Adjusted EPS $ 0.46 $ 0.57 $ 0.54 $ 0.39 $ 0.56 $ 0.63 Adjusted operating margin is calculated as follows: Adjusted operating margin Q1 2009* Q2 2009* Q3 2009* Q4 2009* YTD 2009* Q1 2010 Q2 2010 Q3 2010 Q4 2010 YTD 2010 Operating Income $ 9.9 $ 17.1 $ 57.9 $ 52.2 $ 137.1 $ 32.3 $ 58.6 $ 42.0 $ 26.3 $ 159.2 Special items (1) (1.3) 4.6 (27.5) (24.5) (48.7) - (14.5) 5.5 4.2 (4.8) Joint venture equity earnings (12.8) (9.0) (4.8) (3.1) (29.7) (0.8) (7.1) (9.7) (5.5) (23.1) Adjusted operating (loss) income $ (4.2) $ 12.7 $ 25.6 $ 24.6 $ 58.7 $ 31.5 $ 37.0 $ 37.8 $ 25.0 $ 131.3 Sales $ 463.4 $ 496.5 $ 548.3 $ 552.5 $ 2,060.7 $ 604.0 $ 666.2 $ 650.7 $ 585.3 $ 2,506.2 Operating Margin (0.9)% 2.6% 4.7% 4.5% 2.8% 5.2% 5.6% 5.8% 4.3% 5.2% Adjusted operating margin Q1 2011 Q2 2011 Q3 2011 Q4 2011 YTD 2011 Q1 2012 Q2 2012 Q3 2012 Q4 2012 YTD 2012 Operating income (loss) $ 173.4 $ 42.4 $ 33.4 $ (46.2) $ 203.0 $ 37.4 $ 43.3 $ 43.5 $ 13.3 $ 137.5 Special items (1) (127.2) 2.7 4.9 72.9 (46.7) 8.5 11.8 8.3 25.3 53.9 Joint venture equity earnings (5.7) - - - (5.7) - - - - - Adjusted operating income $ 40.5 $ 45.1 $ 38.3 $ 26.7 $ 150.6 $ 45.9 $ 55.1 $ 51.8 $ 38.6 $ 191.4 Sales $ 682.8 $ 723.4 $ 694.0 $ 609.2 $ 2,709.4 $ 745.5 $ 756.6 $ 707.7 $ 651.0 $ 2,860.8 Operating Margin 5.9% 6.2% 5.5% 4.4% 5.6% 6.2% 7.3% 7.3% 5.9% 6.7% 3 Adjusted operating margin Q1 2013 Q2 2013 Q3 2013 Q4 2013 YTD 2013 Q1 2014 Q2 2014 Q3 2014 Q4 2014 YTD 2014 Operating income (loss) $ 40.5 $ 80.7 $ 61.6 $ 48.7 $ 231.5 $ 56.4 $ 49.4 $ 63.6 $ (14.3) $ 155.1 Special items (1) 16.6 (5.2) 10.8 7.8 30.0 22.9 39.8 22.0 80.2 164.9 Adjusted operating income $ 57.1 $ 75.5 $ 72.4 $ 56.5 $ 261.5 $ 79.3 $ 89.2 $ 85.6 $ 65.9 $ 320.0 Sales $ 801.1 $ 1,037.6 $ 1,008.9 $ 923.6 $ 3,771.2 $ 1,002.3 $ 1,005.5 $ 958.4 $ 869.3 $ 3,835.5 Operating Margin 7.1% 7.3% 7.2% 6.1% 6.9% 7.9% 8.9% 8.9% 7.6% 8.3% Adjusted operating margin Q1 2015 Q2 2015 Q3 2015 Q4 2015 YTD 2015 Q1 2016 Q2 2016 Operating income $ 70.1 $ 80.3 $ 69.2 $ 31.3 $ 250.9 $ 71.3 $ 81.5 Special items (1) 9.3 11.9 18.7 31.4 71.3 13.8 10.4 Adjusted operating income $ 79.4 $ 92.2 $ 87.9 $ 62.7 $ 322.2 $ 85.1 $ 91.9 Sales $ 873.1 $ 887.1 $ 841.6 $ 775.8 $ 3,377.6 $ 847.0 $ 861.5 Operating Margin 9.1% 10.4% 10.4% 8.1% 9.5% 10.0% 10.7% Adjusted gross margin is calculated as follows: (In millions) Twelve Months Ended December 31, 2015 Gross margin - GAAP $ 681.5 Special items in gross margin(1) 39.7 Gross margin before special items $ 721.2 Specialty platform percentage of operating income is calculated as follows: Platform operating income mix percentage 2006Y* Q2 2016 Color, Additives and Inks $ 8.9 $ 38.2 Specialty Engineered Materials 3.9 21.4 Designed Structures and Solutions — 1.0 Specialty Platform $ 12.8 $ 60.6 Performance Products and Solutions 64.2 21.3 Distribution 19.2 17.8 Joint ventures 102.9 — Corporate and eliminations 34.5 (18.2) Operating income GAAP $ 233.6 $ 81.5 Less: Corporate and eliminations (34.5) 18.2 Operating income excluding Corporate $ 199.1 $ 99.7 Specialty platform percentage of operating income excluding corporate 6% 61% 4 Adjusted EBITDA and net debt to adjusted EBITDA is calculated as follows: (In millions) Six Months Ended June 30, 2015 Twelve Months Ended December 31, 2015 Six Months Ended June 30, 2016 Trailing Twelve Months Ended June 30, 2016 Income from continuing operations, before income taxes $ 116.7 $ 167.7 $ 123.6 $ 174.6 Interest expense, net 32.3 64.1 29.2 61.0 Depreciation and amortization 50.1 104.3 52.4 106.6 Special items, impact on income (loss) from continuing operations before income taxes(1) 21.2 87.6 24.5 90.9 Accelerated depreciation included in special items (0.3) (6.2) (3.2) (9.1) Adjusted EBITDA(2) $ 220.0 $ 417.5 $ 226.5 $ 424.0 Short-term and current portion of long-term debt $ 18.4 Long-term debt 1,126.2 Total Debt 1,144.6 Less: Cash and cash equivalents (161.4) Net Debt $ 983.2 Net Debt / TTM Adjusted EBITDA 2.3 * Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principal, discontinued operations or the related resegmentation. (1) Special items are a non-GAAP financial measure and are used to determine adjusted earnings.

PET SUPPLY MANUFACTURER D O G T O Y • Tear strength • Durability • Colorability • Formulation must not intentionally contain BPA, heavy metals, latex, natural rubber, phthalates, or SVHC (REACH) • Optimized material processing and tooling through technical services and application development support • Delivered a solution to address regulation and consumer safety concerns Versaflex™ Thermoplastic Elastomer KEY REQUIREMENTS WHY AVIENT? All Rights Reserved. https://www.polyone.com/products/thermoplastic-elastomers/versaflex-thermoplastic-elastomers Pet supply manufacturer

reSound™ OM TPEs